Abstract
AimsThe incidence of RAS/RAF/PI3KA and TP53 gene mutations in colorectal cancer (CRC) is well established. Less information, however, is available on other components of the CRC genomic landscape, which are...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have